While TGF-β may exert tumor-suppressive effects during early melanoma development [36], under sublethal chemotherapy stress, it assumes a more pro-metastatic and fibrogenic phenotype, facilitating epithelial–mesenchymal transition and fibrotic tissue remodeling [20,38]. This evidence concerns the gene TGFB1 and neoplasm.